Achillion Announces Clearance of Investigational New Drug Application for ACH-5228
BLUE BELL, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) — Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to […]
PFSweb Reports Third Quarter 2019 Results
ALLEN, Texas, Nov. 11, 2019 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, is reporting results […]
Bel Announces Agreement to Purchase CUI Power Assets
JERSEY CITY, N.J., Nov. 11, 2019 (GLOBE NEWSWIRE) — Bel Fuse Inc. (“Bel,” or, “the Company”) (Nasdaq:BELFA and Nasdaq:BELFB), a […]
MyoKardia Announces 48-week Data from PIONEER-OLE Study of Mavacamten
Mavacamten’s Safety and Efficacy Profile in the PIONEER Study Maintained Through OneYear in Open-Label Extension Study of 12 Patients with Symptomatic, Obstructive […]
Aehr Receives Follow-on Orders of Over $6 Million for FOX-XP™ Test and Burn-in System and WaferPaks™ for Silicon Photonics Devices
FREMONT, Calif., Nov. 11, 2019 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and […]
Myriad’s Prequel™ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive Prenatal Screening
SALT LAKE CITY, Nov. 11, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global […]
TSX News -
Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram
Cannabinoid content per gram only slightly lower than identical strains grown indoorsCritical quality control tests successfulApproximately 1,000 kg yield per […]
Cara Therapeutics Announces Publication of Difelikefalin (KORSUVA™ Injection) KALM™-1 Phase 3 Trial Results in the New England Journal of Medicine
– Treatment with KORSUVA Injection resulted in statistically significant reduction in pruritus intensity and improvement in itch-related quality of life […]
Futu to Report Third Quarter 2019 Financial Results on November 22, 2019
HONG KONG, Nov. 11, 2019 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (NASDAQ: FHL), a leading tech-driven online […]
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
3Q19 Galafold® (migalastat) Revenue of $48.8M and 1,000+ Patients on Therapy Reflects Continued Strong Global [...]
